-
EU approves AstraZeneca's Imfinzi─in combo with chemotherapy to treat patients with resectable non─small cell lung cancer
05 Apr 2025 07:44 GMT
… Lung cancer is broadly split into NSCLC and small cell lung cancer … portfolio includes leading lung cancer medicines and the … including Tagrisso (osimertinib) and Iressa (gefitinib); Imfinzi and … improvements for people with lung cancer, including and beyond …
-
Vokes Explores Biomarker Testing and Treatment Landscape for EGFR-Mutated Lung Cancer
18 Mar 2025 17:02 GMT
… patients with non–small cell lung cancer (NSCLC)?
VOKES: The … In] patients with metastatic lung cancer who have a targetable driver … we switched to gefitinib [Iressa] because there were better … of Lung Cancer global survey on molecular testing in lung cancer. J …
-
EU approves AstraZeneca's Imfinzi as monotherapy to treat adults with limited─stage small cell lung cancer
18 Mar 2025 13:14 GMT
… limited-stage small cell lung cancer (LS-SCLC) whose … portfolio includes leading lung cancer medicines and the … including Tagrisso (osimertinib) and Iressa (gefitinib); Imfinzi and Imjudo … improvements for people with lung cancer, including and beyond …
-
EMA committee recommends approval of AstraZeneca's Imfinzi in combo with chemotherapy to treat resectable non─small cell lung cancer
04 Mar 2025 07:39 GMT
… Lung cancer is broadly split into NSCLC and small cell lung cancer … portfolio includes leading lung cancer medicines and the … including Tagrisso (osimertinib) and Iressa (gefitinib); Imfinzi and … improvements for people with lung cancer, including and beyond …
-
Imfinzi recommended for approval in European Union for the treat of adults with limited-stage small cell lung cancer
04 Feb 2025 22:22 GMT
… limited-stage small cell lung cancer. If approved, these … in this indication.
Lung cancer is the leading … lung cancer medicines and the next wave of innovations, including (osimertinib) and Iressa … improvements for people with lung cancer, including and beyond …
-
AstraZeneca's Imfinzi receives US FDA approval to treat patients with limited─stage small cell lung cancer
06 Dec 2024 04:06 GMT
… extensive-stage small cell lung cancer, underscoring our commitment … portfolio includes leading lung cancer medicines and the … including Tagrisso (osimertinib) and Iressa (gefitinib); Imfinzi and … improvements for people with lung cancer, including and beyond …
-
US FDA approves AstraZeneca's Tagrisso for patients with unresectable, stage III EGFR─mutated lung cancer
27 Sep 2024 06:10 GMT
… diagnosed with lung cancer globally. Lung cancer is the … Lung cancer is broadly split into NSCLC and small cell lung cancer … lung cancer medicines and the next wave of innovations, including Tagrisso and Iressa … for people with lung cancer, including and beyond …
-
KRASG12C Inhibitors in Non-Small Cell Lung Cancer: A Review
24 Aug 2024 10:55 GMT
… Abbreviations
LC, Lung cancer; NSCLC, Non-small cell lung cancer; BMs, … -1
14. EMA. Iressa Summary of Product Characteristics; … characterization of squamous cell lung cancers. Nature. 2012;489 … positive non-small cell lung cancer. Lung Cancer. 2020;146(1): …
-
EU approves AstraZeneca's Tagrisso with addition of chemotherapy as new 1st─line treatment for patients with EGFR─mutated advanced lung cancer
06 Jul 2024 07:05 GMT
… deaths. Lung cancer is broadly split into NSCLC and small cell lung cancer. Each … lung cancer medicines and the next wave of innovations, including Tagrisso and Iressa … meaningful improvements for people with lung cancer, including and beyond treatment.
…
-
AstraZeneca's Tagrisso with addition of chemotherapy approved in Japan to treat patients with EGFR─mutated advanced lung cancer
26 Jun 2024 04:54 GMT
… for patients with EGFR-mutated lung cancer either in combination with chemotherapy … deaths. Lung cancer is broadly split into NSCLC and small cell lung cancer. Each … lung cancer medicines and the next wave of innovations, including Tagrisso and Iressa …
About
© 1995-2025